Transaction · 0002014440-26-000012

Anderson Woodrow D

Anderson Woodrow D, CAO, reported an open-market or private purchase at Indivior Pharmaceuticals, Inc. involving 1500.000000 shares for an estimated $53535.00. Reported holdings after the transaction were 27638.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCAO

INDVIndivior Pharmaceuticals, Inc.

Filing timeAug 27

Trade dateAug 27, 2026

Filing · SECView on SEC

InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

…

Pre-filing

…

Returns since

…

INDV price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

INDV since 2026-08-27Filed 8 days ago · 30 days of pre-filing context shaded

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Buy
Identifier: 0002014440-26-000012
Transaction date: Aug 27, 2026
Shares: 1.50k sh
Estimated value: $5.35M
Holdings after: 27.6k sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M

Direct Ownership

+22score

Filing-only score

+22

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Accounting Officer

Officer YesDirector No10% NoOther No

Footnotes & amended

No footnotes recorded.

Original filing · 0002014440-26-000012

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

INDV